Reviving the guardian of the genome: Small molecule activators of p53
Author:
Funder
NIH-NCI
Lady Leukemia League Foundation
Publisher
Elsevier BV
Subject
Pharmacology (medical),Pharmacology
Reference280 articles.
1. Dual targeting of p53 and c-MYC selectively eliminates leukaemic stem cells;Abraham;Nature,2016
2. Driver mutations in TP53 are ubiquitous in high grade serous carcinoma of the ovary;Ahmed;The Journal of Pathology,2010
3. Cisplatin resistance and opportunities for precision medicine;Amable;Pharmacological Research,2016
4. Cancer therapy. Hope for a magic bullet that moves at the speed of light;Amato;Science,1993
5. Results of the phase I trial of RG7112, a small-molecule MDM2 antagonist in leukemia;Andreeff;Clinical Cancer Research,2016
Cited by 62 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. An overview of PROTACs targeting MDM2 as a novel approach for cancer therapy;European Journal of Medicinal Chemistry;2024-06
2. Glioblastoma Therapy: Past, Present and Future;International Journal of Molecular Sciences;2024-02-21
3. The Analysis of Selected miRNAs and Target MDM2 Gene Expression in Oral Squamous Cell Carcinoma;Biomedicines;2023-11-14
4. Targeting Mutant-p53 for Cancer Treatment: Are We There Yet?;Current Molecular Pharmacology;2023-11-03
5. MicroRNA‐215‐5p promotes proliferation, invasion, and inhibits apoptosis in liposarcoma cells by targeting MDM2;Cancer Medicine;2023-05-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3